These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35862018)

  • 1. Fungal Keratitis Treatment Using Drug-Loaded Hyaluronic Acid Microgels.
    Ayyala RS; S Suner S; Bhethanabotla VR; Sahiner N
    ACS Appl Bio Mater; 2022 Aug; 5(8):3806-3815. PubMed ID: 35862018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation and therapeutic effects of β-glucan-specific nanobodies and nanobody-natamycin conjugates in fungal keratitis.
    Liu X; Sui J; Li C; Wang Q; Peng X; Meng F; Xu Q; Jiang N; Zhao G; Lin J
    Acta Biomater; 2023 Oct; 169():398-409. PubMed ID: 37579912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
    Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
    Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
    Mukherjee PK; Chandra J; Yu C; Sun Y; Pearlman E; Ghannoum MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4450-7. PubMed ID: 22669723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
    Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
    Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O; Dugar J; Miller D; OʼBrien TP
    Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
    Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
    Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
    Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
    Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
    Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laccase-mediated functionalization of natamycin by gallic acids for the therapeutic effect on Aspergillus fumigatus keratitis.
    Ji X; Peng X; Long X; Zhang Y; Lin J; Yin J; Zhang R; Zhao G
    Eur J Pharmacol; 2022 Jul; 926():175041. PubMed ID: 35597265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of clioquinol with voriconazole and amphotericin B against fungi of interest in eye infections.
    Reginatto P; Agostinetto GJ; Teixeira ML; de Andrade SF; Fuentefria AM
    J Mycol Med; 2024 Mar; 34(1):101462. PubMed ID: 38290229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.
    Lalitha P; Shapiro BL; Loh AR; Fothergill AW; Prajna NV; Srinivasan M; Oldenburg CE; Quigley DA; Chidambaram JD; McLeod SD; Acharya NR; Lietman TM
    Br J Ophthalmol; 2011 May; 95(5):744-5. PubMed ID: 21030412
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
    Wang L; Wang L; Han L; Yin W
    Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
    Rebong RA; Santaella RM; Goldhagen BE; Majka CP; Perfect JR; Steinbach WJ; Afshari NA
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7309-15. PubMed ID: 21849421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-loaded mesoporous carbon with sustained drug release capacity and enhanced antifungal activity to treat fungal keratitis.
    Gu L; Li C; Lin J; Wang Q; Yin M; Zhang L; Li N; Lin H; You Z; Wang S; Li D; Zhao G
    Biomater Adv; 2022 May; 136():212771. PubMed ID: 35929310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
    Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
    Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.